Skip to main content

Table 3 Summary of findings of two diagnostic methods and sequencing confirmation

From: Molecular diagnosis, phylogenetic analysis, and antifungal susceptibility profiles of Candida species isolated from neutropenic oncological patients

Yeast species

CHROMagarâ„¢ Candida

N (%)

RFLP

Reference sequencing via SANGER *

Frequency

(N: 34)

Size of PCR Amplicon (bp)

Size of MspI -RFLP fragments (bp)

C. albicans

16 (47.05%)

16 (47.05%)

537

239, 298

16 (47.05%)

[OP647129.1

OP647128.1

OP647127.1]

C. glabrata

10 (29.41%)

10 (29.41%)

881

320, 561

10 (29.41%)

[OP650915.1]

C. krusei

4 (12.39%)

4 (12.39%)

510

250, 260

4 (12.39%)

[OP647217.1]

C. parapsilosis

NA

2 (5.88%)

530

530

2 (5.88%)

[OP658936.1

OP658946.1]

C. tropicalis

1 (2.94%)

1 (2.94%)

526

186, 340

1 (2.94%)

[OP658947.1]

C. lambica

NA

NA

NA

NA

1 (2.94%)

[OP658919.1]

  1. *: Due to avoid extra content, all sequences for C. albicans, C. glabrata, and C. krusei were not deposited on the GeneBank
  2. NA: not applicable